Tune in for the second installation of Firefly Fund Co-Founders Pam & Chris Andrews' conversation with Thomas Kirkegaard Jensen Ph.D., Co-Founder and Chief Scientific Officer and Kim Stratton, CEO of Orphazyme, a biopharmaceutical company that translates scientific discoveries into late-stage clinical development programs impacting lives of patients with orphan diseases and their families.